Literature DB >> 23510650

Light weight prosthesis for a patient with bilateral orbital exenteration--a clinical report.

Gunjan Pruthi1, Veena Jain.   

Abstract

PATIENT: This article describes a case report of a patient with history of bilateral orbital exenteration due to squamous cell carcinoma. Spectacle retained acrylic prosthesis was considered to be the best possible option in this case due to total lack of vision and related manual dexterity. DISCUSSION: Main challenge in fabrication of spectacle retained prosthesis is to maintain its adaptation with the tissues during attachment of the screws. So, method of attachment of prostheses with the frame has been discussed in detail. The other concern was the increased weight of the prosthesis and associated discomfort to the patient, as both artificial eyes had to be attached to one frame. Therefore, procedure to reduce the weight of the prosthesis is also discussed.
CONCLUSION: Successful prosthodontic rehabilitation is based on the selection of most suitable maxillofacial prosthetic material and appropriate retentive aid for each patient. Though spectacle retained acrylic prosthesis is a conventional method, it was a user friendly and economical option for this patient.
Copyright © 2013 Japan Prosthodontic Society. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23510650     DOI: 10.1016/j.jpor.2013.01.001

Source DB:  PubMed          Journal:  J Prosthodont Res        ISSN: 1883-1958            Impact factor:   4.642


  2 in total

1.  Prosthetic Rehabilitation of Completely Blind Subject with Bilateral Customised Ocular Prosthesis: A Case Report.

Authors:  Chetan Pathak; Salil Pawah; Gurpreet Singh; Ila Yadav; Shrey Kundra
Journal:  J Clin Diagn Res       Date:  2017-01-01

Review 2.  Advancements in Soft-Tissue Prosthetics Part A: The Art of Imitating Life.

Authors:  Rena L J Cruz; Maureen T Ross; Sean K Powell; Maria A Woodruff
Journal:  Front Bioeng Biotechnol       Date:  2020-03-31
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.